Serpil Ergülü Eşmen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Serpil Ergülü Eşmen has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Firdevs Ulutaş
Department of Rheumatology, Faculty of Medicine, Pamukkale University, Denizli, Türkiye
2 shared publications - Ahmet Anıl Başkurt
Department of Cardiology Bakırçay University Izmir Turkey
1 shared publication - Ahmet Ersecgin
Faculty of Medicine Cardiology Department, Selcuk University, 42075, Konya, Turkey
1 shared publication - Ahmet Yalcin
Division of Geriatrics, Department of Internal Medicine, Faculty of Medicine, Ankara University, 06230 Ankara, Türkiye
1 shared publication - Alexandr Ceasovschih
Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
1 shared publication - Ali Ekin
Van Yüzüncü Yıl University Faculty of Medicine, Division of Rheumatology, Van, Türkiye
1 shared publication
Latest Publications
- 23 June 2025
- Published by Academician Publishing
- p. 235-242
Gout and Other Crystal Arthropathies
Inflammation facilitates both atherogenesis and thrombogenesis in the development of coronary artery disease. Chronic inflammation in any part of the body initiates atherosclerosis and creates a prothrombotic environment. Mortality and the incidence of complications from atherosclerosis are increased in chronic inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus and gout. There are observations regarding the association between gout and risk factors for atherosclerosis. The risk of atherosclerotic disease is increased in patients with gout. Several epidemiological studies showed a positive relationship between the risk of cardiovascular disease and elevated serum uric acid levels. However, asymptomatic hyperuricemia has not been proven as an independent risk factor for atherosclerosis. Although the underlying mechanisms are not well understood, hyperuricemia is associated with many cardiovascular risk factors such as hypertension, obesity, insulin resistance and hyperlipidemia. Therefore, screening and treatment of cardiovascular risk factors are important in patients with gout. İnflamasyon, aterogeneze ve trombogeneze neden olarak koroner arter hastalığının gelişimini kolaylaştırır. Vücudun herhangi bir yerindeki kronik inflamasyon aterosklerozu başlatır ve protrombotik bir ortam yaratır. Romatoid artrit, sistemik lupus eritematozus ve gut gibi kronik inflamatuar hastalıklarda aterosklerozdan kaynaklanan komplikasyonlar ve mortalite artar. Gut hastalarında aterosklerotik hastalık riski artmaktadır. Çeşitli epidemiyolojik çalışmalar, kardiyovasküler hastalık riski ile yüksek serum ürik asit seviyeleri arasında pozitif bir ilişki olduğunu göstermiştir. Bununla birlikte, asemptomatik hiperüriseminin ateroskleroz için bağımsız bir risk faktörü olduğu kanıtlanmamıştır. Altta yatan mekanizmalar tam olarak anlaşılamamış olsa da hiperürisemi, hipertansiyon, obezite, insülin direnci ve hiperlipidemi gibi birçok KV risk faktörü ile ilişkilidir. Gut hastalığı olan hastalarda KV risk faktörleri taranmalı ve tedavisi yapılmalıdır.
- 23 June 2025
- Published by Academician Publishing
- p. 235-242
Gout and Other Crystal Arthropathies
Inflammation facilitates both atherogenesis and thrombogenesis in the development of coronary artery disease. Chronic inflammation in any part of the body initiates atherosclerosis and creates a prothrombotic environment. Mortality and the incidence of complications from atherosclerosis are increased in chronic inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus and gout. There are observations regarding the association between gout and risk factors for atherosclerosis. The risk of atherosclerotic disease is increased in patients with gout. Several epidemiological studies showed a positive relationship between the risk of cardiovascular disease and elevated serum uric acid levels. However, asymptomatic hyperuricemia has not been proven as an independent risk factor for atherosclerosis. Although the underlying mechanisms are not well understood, hyperuricemia is associated with many cardiovascular risk factors such as hypertension, obesity, insulin resistance and hyperlipidemia. Therefore, screening and treatment of cardiovascular risk factors are important in patients with gout. İnflamasyon, aterogeneze ve trombogeneze neden olarak koroner arter hastalığının gelişimini kolaylaştırır. Vücudun herhangi bir yerindeki kronik inflamasyon aterosklerozu başlatır ve protrombotik bir ortam yaratır. Romatoid artrit, sistemik lupus eritematozus ve gut gibi kronik inflamatuar hastalıklarda aterosklerozdan kaynaklanan komplikasyonlar ve mortalite artar. Gut hastalarında aterosklerotik hastalık riski artmaktadır. Çeşitli epidemiyolojik çalışmalar, kardiyovasküler hastalık riski ile yüksek serum ürik asit seviyeleri arasında pozitif bir ilişki olduğunu göstermiştir. Bununla birlikte, asemptomatik hiperüriseminin ateroskleroz için bağımsız bir risk faktörü olduğu kanıtlanmamıştır. Altta yatan mekanizmalar tam olarak anlaşılamamış olsa da hiperürisemi, hipertansiyon, obezite, insülin direnci ve hiperlipidemi gibi birçok KV risk faktörü ile ilişkilidir. Gut hastalığı olan hastalarda KV risk faktörleri taranmalı ve tedavisi yapılmalıdır.
- Open Access
- 17 October 2021
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 88 (5) , S42-S46
Evaluation of nasal mucociliary clearance by saccharine test in rheumatoid arthritis
- 17 October 2021
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 88 (5) , S42-S46
Open AccessEvaluation of nasal mucociliary clearance by saccharine test in rheumatoid arthritis
- 26 April 2021
- Published by Academician Publishing
Covid 19 Pandemisinde Güncel Tıp
- 1 February 2013
- Published by Elsevier in European Geriatric Medicine
- Vol. 4 (1) , 28-31
Markedly elevated erythrocyte sedimentation rate in older adults. How significant clinically?
- 1 February 2013
- Published by Elsevier in European Geriatric Medicine
- Vol. 4 (1) , 28-31
Markedly elevated erythrocyte sedimentation rate in older adults. How significant clinically?